These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4571361)

  • 21. [Kinetometric demonstration of the antispastic action of a GABA derivative (Ciba 34647-BA)].
    Mutani R; Fariello R; Quattrocolo G; Delsedime M
    Riv Neurol; 1971; 41(3):143-51. PubMed ID: 5126431
    [No Abstract]   [Full Text] [Related]  

  • 22. [Schizophrenic and affective disorders in multiple sclerosis. Description of 2 clinical cases].
    Perini G
    Minerva Psichiatr; 1987; 28(2):129-31. PubMed ID: 3695905
    [No Abstract]   [Full Text] [Related]  

  • 23. [Features of muscular electrogenesis and its changes under the influence of midocalm in patients with post-stroke late splasticity].
    Novikova VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1333-40. PubMed ID: 5700604
    [No Abstract]   [Full Text] [Related]  

  • 24. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group.
    Smith C; Birnbaum G; Carter JL; Greenstein J; Lublin FD
    Neurology; 1994 Nov; 44(11 Suppl 9):S34-42; discussion S42-3. PubMed ID: 7970009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [11,447 cases of stroke].
    Osten PE
    Fag Tidsskr Sykepleien; 1992 Feb; 80(1):2-3. PubMed ID: 1596411
    [No Abstract]   [Full Text] [Related]  

  • 26. Functional outcome of intrathecal baclofen administration for severe spasticity.
    Boviatsis EJ; Kouyialis AT; Korfias S; Sakas DE
    Clin Neurol Neurosurg; 2005 Jun; 107(4):289-95. PubMed ID: 15885386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of MS spasticity.
    Pozzilli C
    Eur Neurol; 2014; 71 Suppl 1():1-3. PubMed ID: 24457845
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study of the H reflex in spastic subjects treated with a GABA derivative (Ciba 34647-BA)].
    Fra L; Bergamini L; Brignolio F; Delsedime M
    Riv Neurol; 1971; 41(3):152-60. PubMed ID: 5126432
    [No Abstract]   [Full Text] [Related]  

  • 29. Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis.
    Centonze D; Koch G; Versace V; Mori F; Rossi S; Brusa L; Grossi K; Torelli F; Prosperetti C; Cervellino A; Marfia GA; Stanzione P; Marciani MG; Boffa L; Bernardi G
    Neurology; 2007 Mar; 68(13):1045-50. PubMed ID: 17389310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum treatment for post-stroke spasticity: low dose regime.
    Viriyavejakul A; Vachalathiti R; Poungvarin N
    J Med Assoc Thai; 1998 Jun; 81(6):413-22. PubMed ID: 9676073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Spasticity in multiple sclerosis].
    Pappalardo A; Patti F; Reggio A; Guglielmino A; Mangiameli S
    Clin Ter; 2004 Apr; 155(4):135-8. PubMed ID: 15354762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Urological complications in patients with multiple sclerosis (author's transl)].
    Kiesswetter H; Flamm J; Hennrich F; Summer K; Schober W
    Wien Klin Wochenschr; 1980 Jan; 92(1):16-22. PubMed ID: 6929626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Continuous intrathecal infusion of baclofen. A new therapeutic method for spasticity].
    Berg-Johnsen J; Røste GK; Solgaard T; Lundar T
    Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3256-60. PubMed ID: 9772811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current pharmacologic treatment of multiple sclerosis symptoms.
    Andersson PB; Goodkin DE
    West J Med; 1996 Nov; 165(5):313-7. PubMed ID: 8993211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ataxic nystagmus].
    Larmande AM
    Arch Ophtalmol Rev Gen Ophtalmol; 1968 Sep; 28(6):581-602. PubMed ID: 4235609
    [No Abstract]   [Full Text] [Related]  

  • 36. A phenothiazine derivative in the treatment of spasticity.
    Burke D; Hammond C; Skuse N; Jones RF
    J Neurol Neurosurg Psychiatry; 1975 May; 38(5):469-74. PubMed ID: 1097603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of spasticity management in multiple sclerosis. Evidence-based management strategies for spasticity treatment in multiple sclerosis.
    Haselkorn JK; Balsdon Richer C; Fry Welch D; Herndon RM; Johnson B; Little JW; Miller JR; Rosenberg JH; Seidle ME;
    J Spinal Cord Med; 2005; 28(2):167-99. PubMed ID: 15889701
    [No Abstract]   [Full Text] [Related]  

  • 38. FES cycling reduces spastic muscle tone in a patient with multiple sclerosis.
    Krause P; Szecsi J; Straube A
    NeuroRehabilitation; 2007; 22(4):335-7. PubMed ID: 17971625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple sclerosis.
    Hawker K; Frohman E
    Prim Care; 2004 Mar; 31(1):201-26. PubMed ID: 15110166
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical trials of botulinum toxin in the treatment of spasticity.
    Simpson DM
    Muscle Nerve Suppl; 1997; 6():S169-75. PubMed ID: 9826988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.